»
DCAT WEEK 2015
»
March 16-19, 2015 New York, NY
DCAT Week is one of the largest gatherings for the pharmaceutical and related industries in the world, delivering access to key business partners in one convenient location. Its unique model provides a forum for high-level strategic meetings between pharmaceutical and biopharmaceutical companies and their suppliers. In addition, DCAT Week offers relevant industry education programs and countless networking opportunities, including the DCAT Annual Dinner.
The Drug, Chemical & Associated Technologies Association (DCAT), a not-for-profit, member-supported business development association for the global pharmaceutical manufacturing industry, announces its education programs for DCAT Week ’15, the association’s flagship event being held March 16 to March 19, 2015 at the Waldorf Astoria in New York.
DCAT’s more than 375 member companies are composed of pharmaceutical and biopharmaceutical companies, contract service providers, and suppliers that
represent the full spectrum of the
pharmaceutical manufacturing value chain from raw materials, to drug substances, to drug products, to packaging, to supply chain and logistics. This year marks an important milestone: the 125th anniversary of the founding of DCAT as an organization.
In keeping with a strong tradition, the education programs at DCAT Week ’15 will address the critical issues impacting the pharmaceutical manufacturing value chain. Developed by DCAT’s Education Committee and Education Committee Task Forces, the education programs at DCAT Week ’15 feature leading industry experts offering business intelligence, trend analysis, and executive insight needed to keep pace with a dynamic and increasingly complex pharmaceutical marketplace.
62 | | January/February 2015
IMS Health’s PharmaChem Outlook, FDA’s Quality Metrics Initiative, and Value Creation Through Strategic and Collaborative Sourcing are some of the topics to be addressed.
DCAT Week ’15 will feature six education programs that will provide: an in-depth pharmachem market outlook; the latest on FDA’s Quality Metrics Initiative and its impact on pharma manufacturers and suppliers; the implications of new regulatory and industry programs for excipient GMPs; a review of the biologics market and strategies for managing the biologics supply chain; best practices for collaborative and strategic sourcing; and cutting-edge technologies impacting the future of the pharmaceutical value chain.
DCAT’s 2015 PharmaChem Outlook: Te Market Opportunities and Challenges Monday March 16th, 1:15 to 4:30 PM.
The pharmaceutical industry faces unprecedented challenges. Pharmaceutical companies are confronting greater cost pressures and a higher bar for product innovation that reflects increased demand for value from both regulators and payers. At the same time, growth drivers between developed and emerging markets and the shift to specialty medicines are influencing the direction of the market. Speakers will examine: the strengths and weaknesses of the global pharmaceutical market derived from the latest market data; the financing trends (initial public offerings, venture capital, partnering deals, and mergers and acquisitions) in the biopharmaceutical sector; plus highlights of the most significant deals and investment activity, trends, and valuations of life-science companies in emerging markets. Speakers are: Graham Lewis, Vice President, Global Pharma Strategy, IMS Health; Glen Giovannetti, Global Life Sciences Leader, EY; and Sanjay Sehgal, Managing Partner and CEO, East West Capital Partners.
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76